Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMSCs in chronic renal failure
NCT03321942Unknown
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Jan 2017
- Primary completion
- Dec 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Trial of adipose derived mesenchymal stromal cells in chronic kidney disease (CKD), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoint: serum creatinine at 3 months. Status: unknown.
02
Drugs
adipose derived mesenchymal stromal cells
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT03321942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03321942.